The U.S. Food and Drug Administration has approved a drug to be used for postmenopausal women with advanced hormone-receptor positive and HER2-negative breast cancer.

Obesity. Obesity. Obesity. It's spreading everywhere and touches most every chronic health condition. Now researchers find obesity could affect how well long-term breast cancer treatments work.

Women with large breast cancer tumors usually have two options - have chemotherapy to shrink the tumor before a lumpectomy - or have the entire breast removed. Now there are gentler options.